Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion type Assertion NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_head.
- NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion wasGeneratedBy ECO_0000203 NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_provenance.
- NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion wasDerivedFrom befree-20140225 NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_provenance.
- NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion SIO_000772 23799135 NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_provenance.
- NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion evidence source_evidence_literature NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_provenance.
- NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_assertion description "[The E6-RHDV-VLP-PADRE was administered therapeutically for the treatment of a pre-existing TC-1 tumour and was delivered with antibodies either to deplete regulatory T cells (anti-CD25) or to block T cell suppression mediated through CTLA-4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717236.RA9S7MPWIkw7RaJVn05ZaPPS2z8yq4nDVwbRD-7Cux3jY130_provenance.